rs1555572426
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_032043.3(BRIP1):c.3728_3730delGCAinsTCC(p.GlyMet1243ValLeu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032043.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The c.3728_3730delGCAinsTCC variant (also known as p.G1243_M1244delinsVL), located in coding exon 19 of the BRIP1 gene, results from an in-frame deletion of GCA and insertion of TCC at nucleotide positions 3728 to 3730. This results in the substitution of the glycine and methionine residues for a valine and a leucine residue at codon 1243. This amino acid region is poorly conserved in available vertebrate species. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This variant causes the substitution of two amino acids, glycine and methionine, with valine and leucine at codon 1243 and 1244, respectively, of the BRIP1 protein. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Familial cancer of breast;C1836860:Fanconi anemia complementation group J Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the altered amino acids is currently unknown. This variant has not been reported in the literature in individuals with BRIP1-related disease. ClinVar contains an entry for this variant (Variation ID: 530345). This variant is reported as two separate single-nucleotide changes in population databases (c.3728G>T, ExAC 0.002% and c.3730A>C, ExAC 0.002%). However, in the read data for 1/120838 individuals displayed in the ExAC browser, these two variants are in cis. This recapitulates the variant observed here (c.3728_3730delinsTCC) and indicates that this variant is very likely present in the population databases at 0.002%. This variant, c.3728_3730delinsTCC, is a complex sequence change that results in the deletion of 2 amino acids and insertion of another 2 amino acids of the BRIP1 protein (p.Gly1243_Met1244delinsValLeu). -
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Not observed at a significant frequency in large population cohorts (Lek 2016) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at